Medochemie was established by Dr. Andreas Pittas in 1976 and now ranks among the top 200 generic pharmaceutical companies in the world. It is responsible for an impressive 28.9% of Cypriot Exports and employs 1.880 people globally – 60% of whom are scientists.
Medochemie has acquired 4,355 marketing authorization licenses for 630 different pharmaceutical products, classified in over 10 therapeutic categories, offering to 300 million people around the globe quality and affordable drug treatment. Medochemie has 22 core offices worldwide, it operates in 107 countries and owns 13 manufacturing plants and facilities, of which nine are in Cyprus, one in the Netherlands, and three in Vietnam.
Offering to society as a whole is at the top of its core values and has committed to improving life quality while respecting the ecosystem. Medochemie is involved with many social activities including, environmental protection, public health, and culture. With the target to continuously evolve and advance, Medochemie has received multiple awards, establishing its passion, dedication, and expertise in healthcare.
1-10 Constantinoupoleos St. 3011 Limassol
Tel.: +357 25 867600
Fax: +357 25 560863